Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Yu. Ye. Balykina"'
Autor:
A. S. Kolbin, D. V. Vlodavets, A. A. Kurylev, Yu. Ye. Balykina, M. A. Proskurin, S. A. Mishinova, O. Yu. Germanenko, N. Yu. Kolbina
Publikováno v:
Фармакоэкономика, Vol 13, Iss 4, Pp 337-354 (2021)
Introduction. Spinal muscular atrophies (SMA) are clinically and genetically heterogeneous congenital orphan diseases that lead to progressive spinal motoneurons degeneration and loss of their function. There are 4 types of SMA with type I being the
Externí odkaz:
https://doaj.org/article/91dec5cb41064a93b26b711223acd559
Autor:
A. A. Kolbin, M. V. Naprienko, A. R. Artemenko, I. A. Vilyum, N. V. Latysheva, M. A. Proskurin, Yu. Ye. Balykina
Publikováno v:
Качественная клиническая практика, Vol 0, Iss 3, Pp 26-44 (2019)
Introduction. Results of both clinical and epidemiological studies demonstrate a high frequency of work incapacity associated with headache, reduced socio-economic activity, low quality of life, greater number of comorbid diseases and mental disorder
Externí odkaz:
https://doaj.org/article/11be59cdc5a4492daddff819d8b2ed1c
Publikováno v:
Современная онкология, Vol 16, Iss 2, Pp 66-72 (2014)
Purpose of the study is to perform first line Giotrif® (afatinib) health economic assessment in patients with metastatic NSCLC with EGFR mutations. Markov model and budget impact model were implemented to simulate afatinib monotherapy in treatment o
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doajarticles::70c40b2c39780485a15a36df930a55fd
https://modernonco.orscience.ru/1815-1434/article/view/26966
https://modernonco.orscience.ru/1815-1434/article/view/26966